Freve Jonathan 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Mar 9, 2020
Insider Transaction Report
Form 4
Freve Jonathan
CFO, Treasurer & Secretary
Transactions
- Award
Stock Option (Right to Buy)
2020-03-05+25,000→ 25,000 totalExercise: $1.41Exp: 2030-03-04→ Common Stock (25,000 underlying) - Award
Restricted Stock Units
2020-03-05+25,000→ 25,000 total→ Common Stock (25,000 underlying)
Footnotes (3)
- [F1]This option was granted on March 5, 2020, with 25% of the shares subject to the option vesting on March 5, 2021 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Spring Bank Pharmaceuticals, Inc. common stock.
- [F3]The restricted stock units will vest in two installments. Fifty percent will vest on March 5, 2021 and the remaining fifty percent will vest on December 31, 2021.